Kraig Biocraft Laboratories KBLB Ratios (2010-2026)

OTC KBLB
$0.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

Kraig Biocraft Laboratories Quarterly Ratios

Periods 60 quarters
Latest Jun 2026

Kraig Biocraft Laboratories ratios data for the quarter ended Jun 2026. These financial ratios cover 60 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Mar2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
EBT Margin
EBIT Margin
EBITDA Margin
Operating Margin
Net Margin
FCF Margin
Efficiency
Inventory AverageInventory Avg.
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.03M0.08M
Assets AverageAssets Avg.
2.71M3.71M3.18M3.81M5.02M5.22M4.78M4.37M4.00M3.74M3.43M3.00M2.50M2.12M1.77M1.41M1.45M1.97M2.46M3.42M
Invested CapitalInvested Cap.
1.79M0.96M1.70M2.99M3.38M3.47M3.91M3.49M3.22M2.93M-4.05M-4.60M-5.35M-5.74M-6.53M-6.93M-6.86M-6.39M-6.51M-5.26M
Asset Utilization RatioAsset Util.
Leverage & Solvency
Interest Coverage RatioInterest Cover
-3.53-4.63-3.64-3.37-1.80-7.03-6.94-4.13-4.03-3.77-9.46-3.45-11.35-3.19-5.27-4.14-4.49-9.94-5.01-4.65
Debt Ratio
1.672.062.321.541.321.451.621.812.012.190.510.590.730.801.071.231.020.660.580.35
Times Interest Earned
-3.53-4.63-3.64-3.37-1.80-7.03-6.94-4.13-4.03-3.77-9.46-3.45-11.35-3.19-5.27-4.14-4.49-9.94-5.01-4.65
Valuation
Price to EarningsP/E
-38.14-25.63-65.34-82.33-56.57-63.24-32.74-91.16-70.17-56.44-31.36-204.45-84.04-215.73-110.18-156.57-115.97-64.17-125.67-122.63
Price to SalesP/S
Price to BookP/B
-20.94-13.84-14.36-21.01-15.56-13.54-8.80-12.80-9.16-6.20-7.28-16.64-19.36-12.70-11.51-10.99-9.94-12.17-12.37-16.52
Enterprise Value
101.35M78.59M73.28M81.79M53.47M46.53M26.70M47.75M37.48M27.34M38.14M100.82M132.40M91.09M91.98M91.96M82.77M94.80M96.58M107.37M
EV to EBIT
-143.72-90.07-141.79-149.87-99.63-88.58-51.98-98.13-77.97-59.51-32.10-224.69-89.09-214.93-128.47-158.43-129.79-66.12-133.65-152.64
EV to EBITDA
-143.72-90.07-141.79-149.87-99.63-88.58-51.98-98.13-77.97-59.51-32.10-224.69-89.09-214.93-128.47-158.43-129.79-66.12-133.65-152.64
Market Capitalization
105.02M81.70M76.07M86.18M58.73M51.25M31.00M51.67M41.33M31.00M41.53M103.84M134.99M93.45M93.84M93.94M84.21M96.86M98.98M111.53M
Price to FCFP/FCF
-191.59-159.05-184.47-179.79-122.14-105.57-70.20-130.66-151.64-124.64-126.74-212.12-264.28-286.44-183.09-216.21-190.03-209.72-219.42
EV to FCF
-184.89-153.01-177.70-170.63-111.21-95.84-60.47-120.74-137.49-109.93-116.38-205.95-259.21-279.19-179.46-211.66-186.79-205.26-214.11
EV to CFO
-184.89-179.08-185.45-170.63-111.21-95.84-60.47-120.74-137.49-109.93-116.38-205.95-259.21-279.19-179.46-211.66-186.79-205.26-214.88
Return Ratios
Return on Sales [ROS]ROS
Return on Capital Employed [ROCE]ROCE
40.89%51.42%55.36%55.26%60.25%60.80%64.45%53.91%46.30%40.13%47.93%43.28%53.87%49.14%39.17%38.10%27.49%41.02%42.27%46.74%
Return on Invested Capital [ROIC]ROIC
Return on Assets [ROA]ROA
-186.00%-203.22%-253.16%-214.05%-128.28%-77.84%-80.36%-76.98%-72.76%-71.00%-88.34%-98.94%-159.76%-182.37%-192.48%-247.47%-179.61%-186.80%-147.23%-115.04%